Y-Intercept (HK)’s Sutro Biopharma STRO Stock Holding History

Y-Intercept (HK)’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Buy	+55,879	New	+$1.74M	0.04%	746
2025 Q3	–	Sell	-6,659	Closed	-$47.5K	–	2027
2025 Q2	$47.5K	Buy	+6,659	New	+$54.5K	﹤0.01%	1561
2023 Q3	–	Sell	-1,419	Closed	-$66K	–	1567
2023 Q2	$66K	Buy	+1,419	New	+$70.6K	0.01%	1174

Other funds holding STRO

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Y-Intercept (HK)'s STRO Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Sutro Biopharma (STRO) in Q2 2026: 55,879 shares worth $1.86M. The stake represents 0.04% of the portfolio and ranks #746 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in STRO as recently as Q2 2025.

Y-Intercept (HK) first reported a position in STRO in Q2 2023 and has held it in 3 quarters since. 2 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

Y-Intercept (HK) held 55,879 shares of Sutro Biopharma worth $1.86M as of Q2 2026.
Sutro Biopharma was a new Y-Intercept (HK) position in Q2 2026.
Sutro Biopharma made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #746 holding.
Y-Intercept (HK) first reported a position in Sutro Biopharma in Q2 2023 and has held it in 3 quarters since.
2 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.